Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15215-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15215-1-AP, RRID:AB_11182172
- Product name
- CNPY3 antibody
- Antibody type
- Polyclonal
- Description
- CNPY3 antibody (Cat. #15215-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references CNPY3's regulation of tumor microenvironment and its impact on colon cancer aggressiveness.
TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementia.
Generation of CNPY3 knock out cell line in the H1 (WA01) hESC background.
Canopy FGF signaling regulator 3 affects prognosis, immune infiltration, and PI3K/AKT pathway in colon adenocarcinoma.
The SLITRK4-CNPY3 axis promotes liver metastasis of gastric cancer by enhancing the endocytosis and recycling of TrkB in tumour cells.
A novel rare variant of CNPY3 from familial NMOSD impairs the TLR-mediated immune response.
Gao X, Zhou B, Feng X, Ji Z, Li Q, Liu H
Molecular medicine (Cambridge, Mass.) 2025 Mar 7;31(1):89
Molecular medicine (Cambridge, Mass.) 2025 Mar 7;31(1):89
TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementia.
Arnold FJ, Cui Y, Michels S, Colwin MR, Stockford CM, Ye W, Maheswari Jawahar V, Jansen-West K, Philippe J, Gulia R, Gou Y, Tam OH, Menon S, Situ WG, Cazarez SL, Zandi A, Ehsani KC, Howard S, Dickson DW, Gale Hammell M, Prudencio M, Petrucelli L, Li W, La Spada AR
The Journal of clinical investigation 2025 Jun 2;135(11)
The Journal of clinical investigation 2025 Jun 2;135(11)
Generation of CNPY3 knock out cell line in the H1 (WA01) hESC background.
Qi X, Yao F, Yongli S, Xiaofen Z
Stem cell research 2025 Apr;84:103676
Stem cell research 2025 Apr;84:103676
Canopy FGF signaling regulator 3 affects prognosis, immune infiltration, and PI3K/AKT pathway in colon adenocarcinoma.
Gao XC, Zhou BH, Ji ZX, Li Q, Liu HN
World journal of gastrointestinal oncology 2024 Jul 15;16(7):3284-3298
World journal of gastrointestinal oncology 2024 Jul 15;16(7):3284-3298
The SLITRK4-CNPY3 axis promotes liver metastasis of gastric cancer by enhancing the endocytosis and recycling of TrkB in tumour cells.
Zhou YQ, Bao TS, Xie JX, Yao LL, Yu ST, Li Q, Huang PQ, Zhou WZ, Wang YY, Chen SY, Wang XQ, Zhang XL, Jiang SH, Yi SQ, Zhang ZG, Ma MZ, Hu LP, Xu J, Li J
Cellular oncology (Dordrecht, Netherlands) 2023 Aug;46(4):1049-1067
Cellular oncology (Dordrecht, Netherlands) 2023 Aug;46(4):1049-1067
A novel rare variant of CNPY3 from familial NMOSD impairs the TLR-mediated immune response.
Mo Y, Wang S, Chang Y, Sun X, Liu Z, Sun P, Xu Y, Zhong X, Peng L
Journal of neuroimmunology 2023 Apr 15;377:578065
Journal of neuroimmunology 2023 Apr 15;377:578065
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 15215-1-AP(CNPY3 antibody) at dilution of 1:500
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- IP Result of anti-CNPY3 (IP:15215-1-AP, 3ug; Detection:15215-1-AP 1:500) with mouse kidney tissue lysate 6000ug.
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The CNPY3 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CNPY3. This antibody recognizes human,mouse,rat antigen. The CNPY3 antibody has been validated for the following applications: ELISA, WB, IHC, IP analysis.